Research Article
GMP Compliant Production of a Cryopreserved Adipose-Derived Stromal Cell Product for Feasible and Allogeneic Clinical Use
Table 1
Process steps in the production of the ATIMP for allogeneic clinical application.
| Processes steps | Highlights |
| Donor selection | Young healthy volunteer donors (male and female) | Donor serology/NAT | HIV, hepatitis B and C, syphilis, and HTLV I/II | Procurement | Water assisted liposuction | Starting material (tissue) | Lipoaspirate (abdominal subcutaneous adipose tissue) | Raw materials | Highest grade available | Isolation of SVF | Manual enzymatic digestion | Cell expansion | Closed and semi-automated | Culture conditions | Dynamic and xeno-free | Formulation (excipient) | Cryopreservation media | Quality control methods | According to product specifications | Storage | Liquid nitrogen dry storage | Stability | Storage for two years documented | Clinical use | Allogeneic application |
|
|